Literature DB >> 11487454

Shingles (Herpes Zoster) and Post-herpetic Neuralgia.

Larry E. Davis1, Molly K. King.   

Abstract

During childhood chickenpox, varicella-zoster virus becomes latent in neurons of the dorsal root or trigeminal ganglia. Shingles results years to decades later from a breakdown of viral latency within a ganglion and subsequent virus spread to the skin producing a unilateral dermatomal vesicular rash accompanied by segmental pain. Treatment with famciclovir, valacyclovir, and high dose acyclovir is beneficial if started within the first 3 days of the rash. All three drugs can be given orally, are equally effective, shorten the duration of viral shedding and time to healing of the rash by 1 to 2 days, and lessen the intensity and duration of the acute neuritic pain. Famciclovir and valacyclovir have more convenient dosing schedules (three times daily) compared to acyclovir (five times daily). Mild cases of shingles in younger healthy individuals often do not require any antiviral treatment. Pain in shingles may have burning, lancinating, or allodynic qualities, ranges in intensity from mild to unbearable, and lasts 2 to 8 weeks. Pain treatment varies on the type and intensity of pain experienced. In a few patients, post-herpetic neuralgia develops and the dermatomal pain persists for months to years. Effective treatment of post-herpetic pain is often difficult.

Entities:  

Year:  2001        PMID: 11487454     DOI: 10.1007/s11940-001-0028-3

Source DB:  PubMed          Journal:  Curr Treat Options Neurol        ISSN: 1092-8480            Impact factor:   3.972


  33 in total

1.  Lack of effect of acyclovir on postherpetic neuralgia.

Authors:  M W McKendrick; J I McGill; M J Wood
Journal:  BMJ       Date:  1989-02-18

Review 2.  Otological complications of herpes zoster.

Authors:  K K Adour
Journal:  Ann Neurol       Date:  1994       Impact factor: 10.422

3.  Topical lidocaine patch relieves postherpetic neuralgia more effectively than a vehicle topical patch: results of an enriched enrollment study.

Authors:  B S Galer; M C Rowbotham; J Perander; E Friedman
Journal:  Pain       Date:  1999-04       Impact factor: 6.961

4.  Acyclovir with and without prednisone for the treatment of herpes zoster. A randomized, placebo-controlled trial. The National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group.

Authors:  R J Whitley; H Weiss; J W Gnann; S Tyring; G J Mertz; P G Pappas; C J Schleupner; F Hayden; J Wolf; S J Soong
Journal:  Ann Intern Med       Date:  1996-09-01       Impact factor: 25.391

5.  Intrathecal methylprednisolone for intractable postherpetic neuralgia.

Authors:  N Kotani; T Kushikata; H Hashimoto; F Kimura; M Muraoka; M Yodono; M Asai; A Matsuki
Journal:  N Engl J Med       Date:  2000-11-23       Impact factor: 91.245

6.  Efficacy of oxycodone in neuropathic pain: a randomized trial in postherpetic neuralgia.

Authors:  C P Watson; N Babul
Journal:  Neurology       Date:  1998-06       Impact factor: 9.910

7.  A randomized trial of acyclovir for 7 days or 21 days with and without prednisolone for treatment of acute herpes zoster.

Authors:  M J Wood; R W Johnson; M W McKendrick; J Taylor; B K Mandal; J Crooks
Journal:  N Engl J Med       Date:  1994-03-31       Impact factor: 91.245

8.  Famciclovir for the treatment of acute herpes zoster: effects on acute disease and postherpetic neuralgia. A randomized, double-blind, placebo-controlled trial. Collaborative Famciclovir Herpes Zoster Study Group.

Authors:  S Tyring; R A Barbarash; J E Nahlik; A Cunningham; J Marley; M Heng; T Jones; T Rea; R Boon; R Saltzman
Journal:  Ann Intern Med       Date:  1995-07-15       Impact factor: 25.391

9.  Valaciclovir compared with acyclovir for improved therapy for herpes zoster in immunocompetent adults.

Authors:  K R Beutner; D J Friedman; C Forszpaniak; P L Andersen; M J Wood
Journal:  Antimicrob Agents Chemother       Date:  1995-07       Impact factor: 5.191

Review 10.  Consensus conference on the neurosurgical management of pain.

Authors:  R B North; R M Levy
Journal:  Neurosurgery       Date:  1994-04       Impact factor: 4.654

View more
  2 in total

Review 1.  Famciclovir: a review of its use in herpes zoster and genital and orolabial herpes.

Authors:  Dene Simpson; Katherine A Lyseng-Williamson
Journal:  Drugs       Date:  2006       Impact factor: 9.546

2.  A case of optic neuritis complicating herpes zoster ophthalmicus in a child.

Authors:  Seong Min Hong; Yun Sik Yang
Journal:  Korean J Ophthalmol       Date:  2010-04-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.